Alternatives to argenx
argenx is a BiTech tool: global immunology company developing antibody-based therapies for severe autoimmune diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest BiTech companies to argenx
Viridian Therapeutics, Inc.Not ratedBiopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.
BiotechnologyPharmaceuticalsUpdated 7 May 2026
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
BiotechnologyDrug DiscoveryUpdated 8 Aug 2026
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
BiotechnologyPharmaceuticalsUpdated 19 Aug 2026
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
BiotechnologyPharmaceuticalsUpdated 8 Aug 2026
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
BiotechnologyHealthUpdated 25 Aug 2026
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
BiotechnologyPharmaceuticalsUpdated 30 Aug 2026- EAEarendil LabsNot rated
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
BiotechnologyArtificial IntelligenceUpdated 23 Aug 2026
AlectorNot ratedBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
BiotechMedTechUpdated 1 May 2026- KHKhartis Therapeutics, Inc.Not rated
Developing oral small molecule medicines for immunological and chronic diseases.
BiotechnologyPharmaceuticalsUpdated 14 Aug 2026
Immix Biopharma, Inc.Not ratedA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
BiotechnologyPharmaceuticalsUpdated 22 Jul 2026
ONCOMATRYXNot ratedDeveloping Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
BiotechnologyPharmaceuticalsUpdated 12 Apr 2026
LTZ TherapeuticsNot ratedImmunotherapy company targeting oncology and autoimmune diseases.
BiotechnologyPharmaceuticalsUpdated 13 Sept 2026
Dren BioNot ratedBiopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.
BiotechDrug DiscoveryUpdated 7 Sept 2026
Alchemab TherapeuticsNot ratedDiscovering and developing first-in-class antibody therapeutics by identifying protective antibodies from disease-resilient individuals.
BiotechnologyPharmaceuticalsUpdated 27 Aug 2026
TubulisNot ratedDevelops antibody-drug conjugates (ADCs) for targeted cancer therapy.
BiTechMedTechUpdated 26 Sept 2026
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
BiotechnologymRNA TechnologyUpdated 9 Jul 2026
Adaptive BiotechnologiesNot ratedLeveraging the adaptive immune system to diagnose and treat disease.
BiotechHealthTechUpdated 1 Jul 2026
ImmunaiNot ratedMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
HealthcareImmunologyUpdated 26 Sept 2026
CytoReasonNot ratedDevelops a computational model of the human body for drug discovery and development.
HealthcareDrug DiscoveryUpdated 13 Sept 2026
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
BiotechMedTechUpdated 1 Jul 2026
Showing the 20 closest matches. See the rest on the argenx profile.